Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2012 1
2013 2
2014 5
2015 2
2016 4
2017 8
2018 10
2019 17
2020 30
2021 29
2022 34
2023 41
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Citations

3 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
Cardiovascular health in transgender people.
Irwig MS. Irwig MS. Rev Endocr Metab Disord. 2018 Sep;19(3):243-251. doi: 10.1007/s11154-018-9454-3. Rev Endocr Metab Disord. 2018. PMID: 30073551 Review.
This review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. …
This review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (tra …
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
Connelly PJ, Marie Freel E, Perry C, Ewan J, Touyz RM, Currie G, Delles C. Connelly PJ, et al. Hypertension. 2019 Dec;74(6):1266-1274. doi: 10.1161/HYPERTENSIONAHA.119.13080. Epub 2019 Oct 28. Hypertension. 2019. PMID: 31656099 Free PMC article. Review.
Gender-affirming or cross-sex hormone therapy is integral to the management of transgender individuals yet our appreciation of the effects of such hormones on cardiovascular health is limited. Insights into vascular pathophysiology and outcomes in transgen …
Gender-affirming or cross-sex hormone therapy is integral to the management of transgender individuals yet our appreciation of the ef …
Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
Streed CG Jr, Beach LB, Caceres BA, Dowshen NL, Moreau KL, Mukherjee M, Poteat T, Radix A, Reisner SL, Singh V; American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Stroke Council. Streed CG Jr, et al. Circulation. 2021 Aug 10;144(6):e136-e148. doi: 10.1161/CIR.0000000000001003. Epub 2021 Jul 8. Circulation. 2021. PMID: 34235936 Free PMC article. Review.
Mounting research has revealed that cardiovascular risk factors at the individual level likely do not fully account for increased risk in cardiovascular health disparities among people who are TGD. ...Advancing the cardiovascular health o …
Mounting research has revealed that cardiovascular risk factors at the individual level likely do not fully account for increased ris …
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
Aranda G, Halperin I, Gomez-Gil E, Hanzu FA, Seguí N, Guillamon A, Mora M. Aranda G, et al. Front Endocrinol (Lausanne). 2021 Sep 30;12:718200. doi: 10.3389/fendo.2021.718200. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34659112 Free PMC article. Review.
Transgender men and women represent about 0.6 -1.1%% of the general population. ...In addition, the introduction of GAHT at increasingly earlier ages, even before the full development of the secondary sexual characteristics, could lead to long-term changes in CV risk compa …
Transgender men and women represent about 0.6 -1.1%% of the general population. ...In addition, the introduction of GAHT at increasin …
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Safer J, Slovis J, Tangpricha V, Goodman M. Getahun D, et al. Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10. Ann Intern Med. 2018. PMID: 29987313 Free PMC article.
BACKGROUND: Venous thromboembolism (VTE), ischemic stroke, and myocardial infarction in transgender persons may be related to hormone use. OBJECTIVE: To examine the incidence of these events in a cohort of transgender persons. DESIGN: Electronic medica …
BACKGROUND: Venous thromboembolism (VTE), ischemic stroke, and myocardial infarction in transgender persons may be related to …
Endocrinology of Transgender Medicine.
T'Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. T'Sjoen G, et al. Endocr Rev. 2019 Feb 1;40(1):97-117. doi: 10.1210/er.2018-00011. Endocr Rev. 2019. PMID: 30307546 Review.
Gender-affirming treatment of transgender people requires a multidisciplinary approach in which endocrinologists play a crucial role. ...Future studies should aim to explore the long-term outcome of hormonal treatment in transgender people and provide …
Gender-affirming treatment of transgender people requires a multidisciplinary approach in which endocrinologists play a crucia …
Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment.
Masumori N, Nakatsuka M. Masumori N, et al. Circ Rep. 2023 Mar 28;5(4):105-113. doi: 10.1253/circrep.CR-23-0021. eCollection 2023 Apr 10. Circ Rep. 2023. PMID: 37025940 Free PMC article. Review.
Gender-affirming hormone treatment generally by cross-sex hormones is an important strategy for transgender people to achieve the physical features affirming their experienced gender. ...In this situation, as well as considering the proper use of cross-sex hormones, …
Gender-affirming hormone treatment generally by cross-sex hormones is an important strategy for transgender people to achieve …
Cardiovascular disease in transgender individuals.
Murphy CN, Delles C, Davies E, Connelly PJ. Murphy CN, et al. Atherosclerosis. 2023 Nov;384:117282. doi: 10.1016/j.atherosclerosis.2023.117282. Epub 2023 Sep 9. Atherosclerosis. 2023. PMID: 37821271 Free article. Review.
The population of people identifying as transgender has grown rapidly in recent years, resulting in a substantive increase in individuals obtaining gender-affirming medical care to align their secondary sex characteristics with their gender identity. ...Furthermore, …
The population of people identifying as transgender has grown rapidly in recent years, resulting in a substantive increase in …
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, d'Arminio Monforte A, Vehreschild JJ, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren JD, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Necsoi C, van der Valk M, Menozzi M, Muccini C, Peters L, Mocroft A, Ryom L. Neesgaard B, et al. Lancet HIV. 2022 Jul;9(7):e474-e485. doi: 10.1016/S2352-3018(22)00094-7. Epub 2022 Jun 7. Lancet HIV. 2022. PMID: 35688166
BACKGROUND: Although associations between older antiretroviral drug classes and cardiovascular disease in people living with HIV are well described, there is a paucity of data regarding a possible association with integrase strand-transfer inhibitors (INSTIs). ...RE …
BACKGROUND: Although associations between older antiretroviral drug classes and cardiovascular disease in people living with H …
175 results